Literature DB >> 2328208

Effect of 5-fluorouracil combination therapy on RNA processing in human colonic carcinoma cells.

D A Greenhalgh1, J H Parish.   

Abstract

We have evaluated the RNA-directed cytotoxicity of 5-fluorouracil (5-FU) in human colonic carcinoma cells. The mode of action of 5-FU and its effects on human pre-rRNA processing were then examined. From these data, possible reasons why the disruption of pre-rRNA maturation could induce cytotoxic effects are considered. The results imply that inhibition of thymidylate synthase is not the sole primary cytotoxic lesion in this cell line. First, exogenous thymidine (dTHd) enchanced cytotoxicity. Second, addition of dThd to the cells was found to enhance incorporation of 5-FU into total cellular RNA. Third, 5-FU disrupted rRNA processing by a different mechanism from actinomycin D and methotrexate (MTX), suggesting that the inhibition was not just a consequence of cell death. Finally, the addition of dThd was found to enhance the disruption of rRNA processing consistent with an increase in concentration of 5-FU. These data are discussed in the light of literature reports and their potential for optimising 5-FU protocols.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328208      PMCID: PMC1971286          DOI: 10.1038/bjc.1990.91

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Studies on unbalanced growth in tissue culture. I. Induction and consequences of thymidine deficiency.

Authors:  R R RUECKERT; G C MUELLER
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

3.  The effect of 5-fluorouridine 5'-triphosphate on RNA transcribed in isolated nuclei in vitro.

Authors:  R I Glazer; M Legraverend
Journal:  Mol Pharmacol       Date:  1980-03       Impact factor: 4.436

Review 4.  An update on the biochemistry of 5-fluorouracil.

Authors:  B Ardalan; R Glazer
Journal:  Cancer Treat Rev       Date:  1981-09       Impact factor: 12.111

5.  Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid.

Authors:  D W Kufe; E M Egan
Journal:  Biochem Pharmacol       Date:  1981-01-15       Impact factor: 5.858

Review 6.  "High-dose" thymidine in clinical oncology.

Authors:  S Bruno; D S Poster; V H Bono; J S Macdonald; T T Kubota
Journal:  Cancer Treat Rep       Date:  1981 Jan-Feb

7.  Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.

Authors:  S Spiegelman; R Nayak; R Sawyer; R Stolfi; D Martin
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

8.  5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity.

Authors:  D W Kufe; P P Major
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

9.  Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation.

Authors:  S Spiegelman; R Sawyer; R Nayak; E Ritzi; R Stolfi; D Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA.

Authors:  D W Kufe; P P Major; E M Egan; E Loh
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

View more
  13 in total

Review 1.  RNA modifications: a mechanism that modulates gene expression.

Authors:  John Karijolich; Athena Kantartzis; Yi-Tao Yu
Journal:  Methods Mol Biol       Date:  2010

2.  Functional and structural impact of target uridine substitutions on the H/ACA ribonucleoprotein particle pseudouridine synthase.

Authors:  Jing Zhou; Bo Liang; Hong Li
Journal:  Biochemistry       Date:  2010-07-27       Impact factor: 3.162

3.  Synthesis and characterization of a novel pH-responsive drug-releasing nanocomposite hydrogel for skin cancer therapy and wound healing.

Authors:  Andrea Gonsalves; Pranjali Tambe; Duong Le; Dheeraj Thakore; Aniket S Wadajkar; Jian Yang; Kytai T Nguyen; Jyothi U Menon
Journal:  J Mater Chem B       Date:  2021-12-01       Impact factor: 6.331

4.  5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs.

Authors:  Feng Fang; Jason Hoskins; J Scott Butler
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

5.  RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p.

Authors:  Jason Hoskins; J Scott Butler
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

6.  Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart.

Authors:  C J Hwang; J R Fields; Y-H Shiao
Journal:  Cell Death Dis       Date:  2011-12-08       Impact factor: 8.469

7.  Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo.

Authors:  Xinliang Zhao; Yi-Tao Yu
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

8.  5-Fluorouracil Treatment Alters the Efficiency of Translational Recoding.

Authors:  Junhui Ge; John Karijolich; Yingzhen Zhai; Jianming Zheng; Yi-Tao Yu
Journal:  Genes (Basel)       Date:  2017-10-31       Impact factor: 4.096

Review 9.  Targeting Protein Synthesis in Colorectal Cancer.

Authors:  Stefanie Schmidt; Sarah Denk; Armin Wiegering
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

10.  Inhibiting eukaryotic ribosome biogenesis.

Authors:  Dominik Awad; Michael Prattes; Lisa Kofler; Ingrid Rössler; Mathias Loibl; Melanie Pertl; Gertrude Zisser; Heimo Wolinski; Brigitte Pertschy; Helmut Bergler
Journal:  BMC Biol       Date:  2019-06-10       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.